(19)
(11) EP 4 004 052 A1

(12)

(43) Date of publication:
01.06.2022 Bulletin 2022/22

(21) Application number: 20847569.9

(22) Date of filing: 30.07.2020
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
C12N 5/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/436; A61K 38/4873; A61P 37/02; C07K 16/2803; C07K 16/283; C07K 2317/31; C07K 2317/76; C07K 2317/626; A61K 2039/505; C07K 2317/94; A61K 39/39541; A61K 2039/525; A61K 2039/545; A61K 39/39; A61K 2039/577; A61K 48/0083; C12N 2750/14143; A61K 38/1774; C12Y 304/2201
 
C-Sets:
  1. A61K 38/1774, A61K 2300/00;
  2. A61K 38/4873, A61K 2300/00;
  3. A61K 39/39541, A61K 2300/00;
  4. A61K 31/436, A61K 2300/00;
  5. A61K 39/39, A61K 2300/00;

(86) International application number:
PCT/US2020/044312
(87) International publication number:
WO 2021/022072 (04.02.2021 Gazette 2021/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 30.07.2019 US 201962880240 P

(71) Applicant: Provention Bio, Inc.
Lebanon, New Jersey 08833 (US)

(72) Inventors:
  • LEON, Francisco
    Lebanon, New Jersey 08833 (US)
  • DUNFORD, Paul
    Lebanon, New Jersey 08833 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) METHODS AND COMPOSITIONS FOR REDUCING IMMUNOGENICITY BY NON-DEPLETIONAL B CELL INHIBITORS